Biocept, Inc.
BIOC
|
$0.4349
-10.32%
750K
|
Health Services
(0.0% 1d) (0.0% 1m) (25.9% 1y) (0.0% 2d) (0.0% 3d) (-13.1% 7d) (-9.6% volume)
Earnings Calendar: 2023-04-17
Market Cap: $ 1,142,059
http://www.biocept.com
Sec Filling | Patents | 88 employees
(US) Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample. The company utilizes cell enrichment and extraction technology for the detection and analysis of circulating tumor DNA tests. It also offers services to other laboratory testing providers, academic institutions, research organizations, biopharmaceutical companies and clinical trial support and specific oncogenic alterations. Biocept was founded on May 12, 1997 and is headquartered in San Diego, CA.
tumor cells t-cell clinical trials ceiling
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 44% | 56% |
Top 10 Gainers
KAVL | $6.3 135.96% 51.63% 190K
|
Wholesale Trade
PALI | $4.16 0.97% 49.07% 2.7M
|
Manufacturing
SPCB | $0.4004 45.07% 44.2% 11M
|
Electronic Technology
JAGX | $0.1188 31.56% 35.59% 12M
|
Health Technology
HUBC | $1.95 50.0% 33.67% 4.7M
|
n/a
SNGX | $0.47 21.73% 28.68% 2.7M
|
Health Technology
PRSO | $1.27 -1.55% 27.53% 7.4M
|
Manufacturing
BRTX | $1.32 -1.49% 20.71% 3.3M
|
Professional, Scientific, and T...
ONVO | $1.35 33.65% 19.83% 260K
|
Health Technology
WISA 4 | $1.75 -23.25% 15.56% 14M
|
Electronic Technology
Last 48 Hours Insiders Buying
RMCF | $3.6492 2.51% -7.2% 7.1K
|
Consumer Non-Durables
|
20:10